These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7719580)

  • 21. [Antithrombin therapy of no value in sepsis according to a large clinical trial].
    Gårdlund B
    Lakartidningen; 2002 Mar; 99(13):1456-7, 1460. PubMed ID: 11989356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: reply to two papers.
    Tagami T; Matsui H; Yasunaga H
    J Thromb Haemost; 2015 Apr; 13(4):686-8. PubMed ID: 25650788
    [No Abstract]   [Full Text] [Related]  

  • 23. Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: comment on two papers.
    Wada H; Aota T; Matsumoto T; Suzuki K; Imai H; Katayama N
    J Thromb Haemost; 2015 Apr; 13(4):684-5. PubMed ID: 25611679
    [No Abstract]   [Full Text] [Related]  

  • 24. Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: comment on two papers.
    Iba T
    J Thromb Haemost; 2015 Apr; 13(4):682-3. PubMed ID: 25611174
    [No Abstract]   [Full Text] [Related]  

  • 25. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study: reply.
    Tagami T; Matsui H; Yasunaga H
    J Thromb Haemost; 2015 Apr; 13(4):680-2. PubMed ID: 25530550
    [No Abstract]   [Full Text] [Related]  

  • 26. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study: comment.
    Aota T; Matsumoto T; Suzuki K; Imai H; Katayama N; Wada H
    J Thromb Haemost; 2015 Apr; 13(4):679-80. PubMed ID: 25528989
    [No Abstract]   [Full Text] [Related]  

  • 27. Antithrombin in sepsis revisited.
    Levi M
    Crit Care; 2005; 9(6):624-5. PubMed ID: 16356248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose antithrombin therapy for sepsis.
    Iba T; Kidokoro A
    J Trauma; 2000 Nov; 49(5):979-80. PubMed ID: 11086799
    [No Abstract]   [Full Text] [Related]  

  • 29. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
    Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
    Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early administration of high-dose antithrombin in severe sepsis: single center results from the KyberSept-trial.
    Eid A; Wiedermann CJ; Kinasewitz GT
    Anesth Analg; 2008 Nov; 107(5):1633-8. PubMed ID: 18931224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis.
    Gonano C; Sitzwohl C; Meitner E; Weinstabl C; Kettner SC
    Crit Care; 2006; 10(6):R160. PubMed ID: 17107615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of septicaemia].
    Solberg CO
    Tidsskr Nor Laegeforen; 1974 Mar; 94(9):578-80. PubMed ID: 4828081
    [No Abstract]   [Full Text] [Related]  

  • 33. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations.
    Balk RA
    Dis Mon; 2004 Apr; 50(4):168-213. PubMed ID: 15133467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin).
    Schellongowski P; Bauer E; Holzinger U; Staudinger T; Frass M; Laczika K; Locker GJ; Quehenberger P; Rabitsch W; Schenk P; Knöbl P
    Vox Sang; 2006 May; 90(4):294-301. PubMed ID: 16635072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of coagulation inhibitors in inflammation.
    Esmon CT
    Thromb Haemost; 2001 Jul; 86(1):51-6. PubMed ID: 11487041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pediatric septic shock--timing, volume resuscitation and anticoagulation therapy].
    Kjaergaard S; Goldinger MP; Højberg AS
    Ugeskr Laeger; 2006 Jan; 168(3):289-90. PubMed ID: 16430817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacotherapy of sepsis].
    Guzzo I; Morabito S; Stucchi R; Poli G; Fumagalli R
    G Ital Nefrol; 2006; 23 Suppl 36():S79-86. PubMed ID: 17068734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of protein C concentrate in pediatric patients with sepsis.
    Silvani P; Camporesi A; Licari E; Wolfler A
    Minerva Anestesiol; 2005 Jun; 71(6):373-8. PubMed ID: 15886604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microcirculatory disorders in sepsis and transplantation: therapy with natural coagulatory inhibitors antithrombin and activated protein C.
    Hoffmann JN; Fertmann JM; Jauch KW
    Curr Opin Crit Care; 2006 Oct; 12(5):426-30. PubMed ID: 16943720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.